Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The Path to the First FDA-Approved Cannabis-Derived Treatment and What Comes Next

The Path to the First FDA-Approved Cannabis-Derived Treatment and What Comes Next This Medical News story discusses the history of Epidiolex and whether its approval to treat 2 rare epilepsy syndromes will foster the development of more cannabis-derived therapies. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

The Path to the First FDA-Approved Cannabis-Derived Treatment and What Comes Next

JAMA , Volume 320 (12) – Sep 25, 2018

Loading next page...
 
/lp/american-medical-association/the-path-to-the-first-fda-approved-cannabis-derived-treatment-and-what-vDPEBhoFuA

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright 2018 American Medical Association. All Rights Reserved.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2018.11914
pmid
30193358
Publisher site
See Article on Publisher Site

Abstract

This Medical News story discusses the history of Epidiolex and whether its approval to treat 2 rare epilepsy syndromes will foster the development of more cannabis-derived therapies.

Journal

JAMAAmerican Medical Association

Published: Sep 25, 2018

There are no references for this article.